/Investor DB

Gilde Healthcare — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Axonics Modulation Technologiesaxonics.cominJul 2017 · $20M

Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions.

HealthtechMedical DevicesIrvine, US

Michael Williamson(Executive Officer)Dan L. Dearen(Executive Officer)inRaymond Cohen(Executive Officer, Director)in

BoardDarren Cai(Director)Raphael Wisniewski(Director)Erik Amble(Director)

Co-investorsAdvent Life SciencesAndera PartnersLongitude Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.